Regional cardiac dysfunction is associated with specific alterations in inflammatory cytokines and matrix metalloproteinases after acute myocardial infarction in sheep

Basic Research in Cardiology

Volumn 102, Issue 1, 2007, Pages 63-72

  Gallagher, Gabrielle ^a   Menzie, Stuart ^a   Huang, Yifei ^a   Jackson, Chris ^a   Hunyor, Stephen N ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Cytokines; Extracellular matrix; Matrix metalloproteinases; Myocardial contraction; Myocardial infarction

Indexed keywords

CYTOKINE; GELATIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART DILATATION; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEEP; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CYTOKINES; FEMALE; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; SHEEP; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33845589412     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-006-0610-7     Document Type: Article

References (34)

1. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS, Lovett DH (2003) A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunBFra1 and JunB-FosB heterodimers. Biochem J 369:485-496
2. Cleland JG, Coletta AP, Freemantle N, Velavan P, Tin L, Clark AL (2005) Clinical trials update from the American College of Cardiology meeting: CAREHF and the remission of heart failure, Women's Health Study, TNT, COMPASS- HF, VERITAS, CANPAP, PEECH and PREMIER. Eur J Heart Fail 7:931-936
3. Cleutjens JP (1996) The role of matrix metalloproteinases in heart disease. Cardiovasc Res 32:816-821
4. Creemers EE, Davis JN, Parkhurst AM, Leenders P, Dowdy KB, Hapke E, Hauet AM, Escobar PG, Cleutjens JP, Smits JF, Daemen MJ, Zile MR, Spinale FG (2003) Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 284:H364-H371
5. Deten A, Holzl A, Leicht M, Barth W, Zimmer HG (2001) Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 33:1191-1207
6. Deten A, Volz HC, Briest W, Zimmer HG (2002) Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 55:329-340
7. Deten A, Zimmer HG (2002) Heart function and cytokine expression is similar in mice and rats after myocardial infarction but differences occur in TNFalpha expression. Pflugers Arch 445:289-296
8. Donker DW, Volders PG, Arts T, Bekkers BC, Hofstra L, Spatjens RL, Beekman JD, Borgers M, Crijns HJ, Vos MA (2005) End-diastolic myofiber stress and ejection strain increase with ventricular volume overload - Serial in-vivo analyses in dogs with complete atrioventricular block. Basic Res Cardiol 100:372-382
9. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT (2000) Targeted deletion of matrix metalloproteinase- 9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55-62
10. Gao CQ, Sawicki G, Suarez-Pinzon WL, Csont T, Wozniak M, Ferdinandy P, Schulz R (2003) Matrix metalloproteinase- 2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc Res 57:426-433
11. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL et al. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555-557
12. Giricz Z, Lalu MM, Csonka C, Bencsik P, Schulz R, Ferdinandy P (2006) Hyperlipidemia attenuates the infarct sizelimiting effect of ischemic preconditioning: Role of matrix metalloproteinase- 2 inhibition. J Pharmacol Exp Ther 316:154-161
13. Guo C, Piacentini L (2003) Type I collagen- induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts. J Biol Chem 278:46699-46708
14. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z (1986) Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261:2814-2818
15. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135-1142
16. Huang Y, Hunyor SN, Jiang L, Kawaguchi O, Shirota K, Ikeda Y, Yuasa T, Gallagher G, Zeng B, Zheng X (2004) Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses. Am J Physiol Heart Circ Physiol 286: H2141-H2150
17. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen WH, Shou Z, Liu P (1999) Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99:1492-1498
18. Jayasankar V, Woo YJ, Bish LT, Pirolli TJ, Berry MF, Burdick J, Bhalla RC, Sharma RV, Gardner TJ, Sweeney HL (2004) Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy. Circulation 110:II180-II186
19. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML (1995) Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92:1866-1875
20. Lalu MM, Csonka C, Giricz Z, Csont T, Schulz R, Ferdinandy P (2002) Preconditioning decreases ischemia/reperfusion- induced release and activation of matrix metalloproteinase-2. Biochem Biophys Res Commun 296:937-941
21. Li YY, Feng Y, McTiernan CF, Pei W, Moravec CS, Wang P, Rosenblum W, Kormos RL, Feldman AM (2001) Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation. 104:1147-1152
22. Matsusaka H, Ikeuchi M, Matsushima S, Ide T, Kubota T, Feldman AM, Takeshita A, Sunagawa K, Tsutsui H (2005) Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 289:H1858-H1864
23. McQuibban GA, Gong JH, Tam EM, Mc- Culloch CA, Clark-Lewis I, Overall CM (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289:1202-1206
24. Moainie SL, Gorman JH, 3rd, Guy TS, Bowen FW, 3rd, Jackson BM, Plappert T, Narula N, St John-Sutton MG, Narula J, Edmunds LH, Jr., Gorman RC (2002) An ovine model of postinfarction dilated cardiomyopathy. Ann Thorac Surg 74:753-760
25. Puhakka M, Magga J, Hietakorpi S, Penttila I, Uusimaa P, Risteli J, Peuhkurinen K (2003) Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. J Card Fail 9:325-332
26. Rohde LE, Aikawa M, Cheng GC, Sukhova G, Solomon SD, Libby P, Pfeffer J, Pfeffer MA, Lee RT (1999) Echocardiography- derived left ventricular endsystolic regional wall stress and matrix remodeling after experimental myocardial infarction. J Am Coll Cardiol 33:835-842
27. Schonbeck U, Mach F, Libby P (1998) Generation of biologically active IL-1 beta by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 161:3340-3346
28. Siwik DA, Chang DL, Colucci WS (2000) Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86:1259-1265
29. Squire IB, Evans J, Ng LL, Loftus IM, Thompson MM (2004) Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: Correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Fail 10:328-333
30. Tyagi SC, Lewis K, Pikes D, Marcello A, Mujumdar VS, Smiley LM, Moore CK (1998) Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. J Cell Physiol 176:374-382
31. von Haehling S, Jankowska EA, Anker SD (2004) Tumour necrosis factor-alpha and the failing heart - pathophysiology and therapeutic implications. Basic Res Cardiol 99:18-28
32. Wilson EM, Moainie SL, Baskin JM, Lowry AS, Deschamps AM, Mukherjee R, Guy TS, St John-Sutton MG, Gorman JH, 3rd, Edmunds LH, Jr., Gorman RC, Spinale FG (2003) Region- and typespecific induction of matrix metalloproteinases in post-myocardial infarction remodeling. Circulation 107:2857-2863
33. Zhang X, Azhar G, Nagano K, Wei JY (2001) Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts. J Am Coll Cardiol 38:2055-2062
34. Zhong H, Simons JW (1999) Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun 259:523-526